Role of WHO FCTC global knowledge hub on smokeless tobacco in smokeless tobacco control

SMOKELESS TOBACCO SMOKELESS TOBACCO 1. Description of Smokeless Tobacco Practices

Bidis and smokeless tobacco

Bidis and smokeless tobacco are the cheapest, least taxed and most commonly used tobacco products in India. They are highly addictive and high in carcinogens. They cause a broad spectrum of diseases; yet awareness about their ill-effects is low. Smokeless tobacco products containing arecanut, e.g. gutka and mawa, are especially addictive and carcinogenic. The high incidences of oral and lung ca...

Quitting smokeless tobacco

How can a person get help quitting the use of smokeless tobacco? All of the resources in this general area are geared toward helping smokers stop smoking, but a smokeless tobacco nicotine addict does not have a similar usage ritual as a smoker, but does have a similar, or worse, addiction than a smoker because the nicotine absorption levels are many times greater. Any suggestions as to how a sm...

A Policy Perspective on the Global Use of Smokeless Tobacco

Background Globally, over 300 million people consume diverse smokeless tobacco (ST) products. They are addictive, cause cancer, increased cardiovascular mortality risks and poor pregnancy outcomes. Purpose of Review To identify gaps in implementing key ST demand-reduction measures, focused literature reviews were conducted and findings synthesized according to relevant WHO Framework Conventio...

Smokeless tobacco and cardiovascular risk.

This article discusses the evolution of smokeless tobacco in the United States and interprets the available data on cardiovascular risk factors and cardiovascular mortality associated with its use. There has been a resurgence of smokeless tobacco use since 1970. Smokeless tobacco consistently produces levels of nicotine higher than those seen with smoking and causes similar sympathetic neural s...